Kraft Heinz (KHC) says a new wave of inflation is squeezing consumers again, GLP-1 medications are reducing calorie consumption from packaged foods and challenger brands are innovating faster

• These pressures are contributing to industry volumes remaining negative after years of declines.
• Turnaround requires reversing brand underinvestment, lagging innovation and lost distribution, acknowledging the company has not been running its assets as deserved and warning that “iconic does not mean invincible” and brands lose relevance without investment.
• Its three-year strategy targets sustainable, volume-led profitable growth, revenue and profit growth and attractive free cash flow, prioritising faster innovation, stronger brand propositions, better resource allocation and closer retailer partnerships while preserving financial flexibility to fund growth.

Packaged food incumbents acknowledging structural volume pressure in these terms follows a familiar template: an incoming or refreshed management team resets the narrative, concedes underinvestment in brands and distribution, and reframes the strategy around volume-led growth funded by a period of elevated marketing and innovation spend. Comparable resets at large-cap staples have historically meant margin guidance comes down before it goes up, since reinvestment is front-loaded while the volume recovery is back-loaded, and the market's verdict has tended to hinge on whether organic volumes inflect within the first couple of years of the plan rather than on the ambition of the targets. The GLP-1 acknowledgement is notable as company-level confirmation of what sell-side work has argued for some time: appetite-suppressing drug adoption is a demand headwind concentrated in calorie-dense packaged categories, and naming it publicly raises the bar for demonstrating that innovation can offset it rather than merely slow it. The read-across is to the peer set, where volume performance has diverged sharply between companies with pricing power and fresher brands and those reliant on legacy centre-of-store portfolios; challenger brands gaining distribution is the mechanism through which shelf space, once lost, rarely comes back cheaply. Follow-ons worth noting are the cadence of organic volume prints against the plan's milestones, any quantification of the reinvestment envelope and its margin cost, and how the framing interacts with the company's previously explored portfolio separation, since a split narrative and a turnaround narrative sit awkwardly together.